AbbVie Inc - Free Cash Flow To The Firm

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Free-Cash-Flow-To-The-Firm" stands at 21.94 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2024.

AbbVie Inc's third quarter result of 7.09 Billion USD for the item "Free Cash Flow To The Firm" represents an increase of 28.56 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of 7.09 Billion USD for the item "Free Cash Flow To The Firm" represents an increase of 22.77 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of 21.94 Billion USD for the item "Free Cash Flow To The Firm" represents an increase of 6.37 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 23.63 percent compared to the value the year prior.
The 1 year change in percent is 23.63.
The 3 year change in percent is -7.84.
The 5 year change in percent is 26.97.
The 10 year change in percent is 338.60.

The Serie's long term average value is 13.65 Billion United States Dollars. It's latest available value, on 09/30/2025, is 60.74 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 09/30/2025, is +563.23%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -17.71%.